Validation of the “budget impact analysis” model of the introduction of dolutegravir drug into the public procurement of antiretroviral drugs in the Russian Federation

V.V. Babiy; A.Yu. Kulikov

doi:10.30809/phe.3.2017.2

Validation of the “budget impact analysis” model of the introduction of dolutegravir drug into the public procurement of antiretroviral drugs in the Russian Federation

Pharmacoeconomics theory and practice ◽

10.30809/phe.3.2017.2 ◽

2017 ◽

Vol 5 (3) ◽

pp. 64-66

Author(s):

V.V. Babiy ◽

A.Yu. Kulikov

Keyword(s):

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Public Procurement ◽

Antiretroviral Drugs ◽

Budget Impact Analysis ◽

Analysis Model ◽

The Public ◽

The Russian Federation

Download Full-text

PND56 BUDGET IMPACT ANALYSIS OF INCLUSION IN THE PUBLIC FINANCING OCRELIZUMAB THERAPY FOR PRIMARY-PROGREDIENT AND HIGHLY ACTIVE REMITTING FORMS OF MULTIPLE SCELEROSIS IN THE RUSSIAN FEDERATION

Value in Health ◽

10.1016/j.jval.2019.09.1826 ◽

2019 ◽

Vol 22 ◽

pp. S747

Author(s):

M. Holownia-Voloskova ◽

T. Ermolaeva ◽

D. Klabukova ◽

A. Fisun ◽

K. Poliakova ◽

...

Keyword(s):

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Public Financing ◽

The Public ◽

Highly Active ◽

The Russian Federation

Download Full-text

Budget Impact Analysis on the intranasal form of Interferon-Gamma in the Complex Therapy of Influenza in the Russian Federation

International Journal of Pharmaceutical Research ◽

10.31838/ijpr/2018.10.04.053 ◽

2021 ◽

Vol 10 (04) ◽

Keyword(s):

Interferon Gamma ◽

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Complex Therapy ◽

The Russian Federation

Download Full-text

Budget Impact Analysis Of Formoterol Easyhaler In The Treatment Of Asthma In Children In The Russian Federation

Value in Health ◽

10.1016/j.jval.2015.09.1396 ◽

2015 ◽

Vol 18 (7) ◽

pp. A497

Author(s):

A Kulikov ◽

E Kilimanova

Keyword(s):

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

The Russian Federation ◽

Asthma In Children

Download Full-text

BUDGET IMPACT ANALYSIS OF SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS IN THE RUSSIAN FEDERATION

Pharmacoeconomics theory and practice ◽

10.30809/phe.2.2020.3 ◽

2020 ◽

Vol 8 (2) ◽

pp. 23-28

Author(s):

V.G Serpik ◽

A.Yu Kulikov ◽

T.V Dubinina ◽

M.V Protsenko

Keyword(s):

Ankylosing Spondylitis ◽

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

The Russian Federation

Download Full-text

PRO40 BUDGET IMPACT ANALYSIS OF IDURSULFASE BETA IN THE TREATMENT MUCOPOLYSACCHARIDOSIS TYPE II IN THE RUSSIAN FEDERATION

Value in Health ◽

10.1016/j.jval.2019.09.2370 ◽

2019 ◽

Vol 22 ◽

pp. S848

Author(s):

R. Yagudina ◽

A. Kulikov ◽

V. Serpik ◽

E. Kostina

Keyword(s):

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Mucopolysaccharidosis Type ◽

Type Ii ◽

Mucopolysaccharidosis Type Ii ◽

The Russian Federation

Download Full-text

Budget Impact Analysis of Cerebrolysin In The Treatment of Acute Ischemic Stroke of Moderate and Severe Degrees of Severity In The Russian Federation

Value in Health ◽

10.1016/j.jval.2015.09.2612 ◽

2015 ◽

Vol 18 (7) ◽

pp. A699

Author(s):

A Kulikov ◽

G Abdrashitova

Keyword(s):

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

The Russian Federation ◽

Degrees Of Severity

Download Full-text

PRS54 BUDGET IMPACT ANALYSIS OF THE DUPILUMAB IN THE TREATMENT PATIENTS WITH SEVERE BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

Value in Health ◽

10.1016/j.jval.2020.04.1373 ◽

2020 ◽

Vol 23 ◽

pp. S358

Author(s):

R. Yagudina ◽

A. Kulikov ◽

V. Serpik ◽

V. Ryagina

Keyword(s):

Bronchial Asthma ◽

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

The Russian Federation

Download Full-text

Budget Impact Analysis of Dasatinib as a Second-Line Therapy in Patients with Chronic Myelogenous Leukemia (Cml) in the Russian Federation

Value in Health ◽

10.1016/j.jval.2015.09.1085 ◽

2015 ◽

Vol 18 (7) ◽

pp. A441-A442

Author(s):

A Kulikov ◽

R Yagudina ◽

MV Protsenko

Keyword(s):

Chronic Myelogenous Leukemia ◽

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Myelogenous Leukemia ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

The Russian Federation

Download Full-text

PIH3 BUDGET IMPACT ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.210 ◽

2019 ◽

Vol 19 ◽

pp. S36

Author(s):

R. Yagudina ◽

A. Kulikov ◽

V. Serpik ◽

V. Krylov

Keyword(s):

Russian Federation ◽

Ovarian Stimulation ◽

Impact Analysis ◽

Budget Impact ◽

Ovarian Response ◽

Budget Impact Analysis ◽

Controlled Ovarian Stimulation ◽

The Russian Federation

Download Full-text

Budget Impact Analysis of Botulinium Toxin Type A In Treatment of Post-Stroke Spasticity In The Russian Federation

Value in Health ◽

10.1016/j.jval.2015.03.913 ◽

2015 ◽

Vol 18 (3) ◽

pp. A157

Author(s):

R. Yagudina ◽

A. Kulikov ◽

D. Ugrekhelidze

Keyword(s):

Russian Federation ◽

Impact Analysis ◽

Budget Impact ◽

Type A ◽

Budget Impact Analysis ◽

Post Stroke ◽

The Russian Federation

Download Full-text